CD40LG and COVID-19: However, the sensitivity of the VivaDiag COVID-19 IgM/IgG Rapid Test was only 18.4% in blood samples of acute COVID-19 patients from the emergency department [76], suggesting that serological tests require more research before being deemed suitable for routine diagnosis.